Skip to main content
Top
Published in: Thyroid Research 1/2013

Open Access 01-12-2013 | Research

Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjects

Authors: Rosita Fontes, Claudia Regina Coeli, Fernanda Aguiar, Mario Vaisman

Published in: Thyroid Research | Issue 1/2013

Login to get access

Abstract

Background

Studies based on laboratory data about thyroid stimulating hormone (TSH) and free thyroxine (FT4) reference interval (RI) show conflicting results regarding the importance of using specific values by age groups with advancing age. Retrospective laboratory data or non-specific criteria in the selection of subjects to be studied may be factors leading to no clear conclusions. The aim of this study is to test the hypothesis that TSH and FT4 have specific RI for subjects over 60 to 80 years.

Methods

We evaluated prospectively 1200 subjects of both sexes stratified by age groups, initially submitted to a questionnaire to do the first selection to exclude those with factors that could interfere in TSH or FT4 levels. Then, we excluded those subjects with goiter or other abnormalities on physical examination, positive thyroid peroxidase antibodies (TPOAb), thyroglobulin antibodies (TGAb), and other laboratory abnormalities.

Results

TSH increased with age in the whole group. There was no statistical difference in the analysis of these independent subgroups: 20–49 versus 50–59 years old (p > 0.05), and 60–69 versus 70–79 years old (p > 0.05). Consequently, we achieved different TSH RI for the three major age groups, 20 to 59 years old: 0.4 - 4.3 mU/L, 60 to 79 years old: 0.4 - 5.8 mU/L and 80 years or more: 0.4 - 6.7 mU/L. Conversely, FT4 progressively decreases = significantly with age, but the independent comparison test between the sub-groups showed that after age 60 the same RI was obtained (0.7 - 1.7 ng/dL) although the minimum value was smaller than that defined by manufacturer. In the comparison between TSH data obtained by this study and those defined by the manufacturer (without segmentation by age) 6.5% of subjects between 60 and 79 years and 12.5% with 80 years or more would have a misdiagnosis of elevated TSH.

Conclusions

TSH normal reference range increases with age, justifying the use of different RI in subjects 60 years old and over, while FT4 decreases with age. Using specific-age RI, a significant percentage of elderly will not be misdiagnosed as having subclinical hipothyroidism.
Appendix
Available only for authorised users
Literature
1.
go back to reference United Nations publication: The Sex and Age distribution of the world populations. Sex and Age Popul Div, United Nations Secretariat, the 1998 Revis 1998, I: 2–6. No. E.99.XIII.8 United Nations publication: The Sex and Age distribution of the world populations. Sex and Age Popul Div, United Nations Secretariat, the 1998 Revis 1998, I: 2–6. No. E.99.XIII.8
2.
go back to reference Chiovato L, Mariotti S, Pinchera A: Thyroid diseases in the elderly. Baillieres Clin Endocrinol Metab 1997, 11: 251–270. 10.1016/S0950-351X(97)80272-8PubMedCrossRef Chiovato L, Mariotti S, Pinchera A: Thyroid diseases in the elderly. Baillieres Clin Endocrinol Metab 1997, 11: 251–270. 10.1016/S0950-351X(97)80272-8PubMedCrossRef
3.
go back to reference Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160: 526–534. 10.1001/archinte.160.4.526PubMedCrossRef Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160: 526–534. 10.1001/archinte.160.4.526PubMedCrossRef
4.
go back to reference Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE: Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87: 489–499. 10.1210/jc.87.2.489PubMedCrossRef Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE: Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87: 489–499. 10.1210/jc.87.2.489PubMedCrossRef
6.
go back to reference Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, Pesce A, Sine HE, Zakovski J: Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline – Third Edition. Clin Lab Stand Inst 2008, 28: C28-A3. Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, Pesce A, Sine HE, Zakovski J: Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline – Third Edition. Clin Lab Stand Inst 2008, 28: C28-A3.
7.
go back to reference Kahapola-Arachchige KM, Hadlow N, Wardrop R, Lim EM, Walsh JP: Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol 2012, 77: 773–779. 10.1111/j.1365-2265.2012.04463.xCrossRef Kahapola-Arachchige KM, Hadlow N, Wardrop R, Lim EM, Walsh JP: Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol 2012, 77: 773–779. 10.1111/j.1365-2265.2012.04463.xCrossRef
8.
go back to reference Vadiveloo T, Donnan PT, Murphy MJ, Leese GP: Age- and gender-specific TSH reference intervals in People with no obvious Thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study (TEARS). J Clin Endocrinol Metab 2013, 98: 1147–1153. 10.1210/jc.2012-3191PubMedCrossRef Vadiveloo T, Donnan PT, Murphy MJ, Leese GP: Age- and gender-specific TSH reference intervals in People with no obvious Thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study (TEARS). J Clin Endocrinol Metab 2013, 98: 1147–1153. 10.1210/jc.2012-3191PubMedCrossRef
10.
go back to reference Netto LS, Coeli CM, Micmacher E, Mamede SC, Nazar LO, Correa EK, Arrastia M, Galvão D, Buescu A, Vaisman M: Longitudinal study of pituitary-thyroid axis in pregnancy. Arq Bras Endocrinol Metab 2004, 48: 493–498.CrossRef Netto LS, Coeli CM, Micmacher E, Mamede SC, Nazar LO, Correa EK, Arrastia M, Galvão D, Buescu A, Vaisman M: Longitudinal study of pituitary-thyroid axis in pregnancy. Arq Bras Endocrinol Metab 2004, 48: 493–498.CrossRef
11.
go back to reference Resultado do Monitoramento do Teor de Iodo no Sal: Results of monitoring of iodine in salt. 2011. Resultado do Monitoramento do Teor de Iodo no Sal: Results of monitoring of iodine in salt. 2011.
12.
go back to reference Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklin JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228–238. 10.1001/jama.291.2.228PubMedCrossRef Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklin JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ: Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228–238. 10.1001/jama.291.2.228PubMedCrossRef
13.
go back to reference Oppenheimer JH, Schwartz HL, Dillman W, Surks MI: Effect of thyroid hormone analogues on the displacement of 125 I-L-triiodothyronine from hepatic and heart nuclei in vivo: possible relationship to hormonal activity. Bioch Bioph Res Commun 1973, 55: 544–550. 10.1016/0006-291X(73)91177-7CrossRef Oppenheimer JH, Schwartz HL, Dillman W, Surks MI: Effect of thyroid hormone analogues on the displacement of 125 I-L-triiodothyronine from hepatic and heart nuclei in vivo: possible relationship to hormonal activity. Bioch Bioph Res Commun 1973, 55: 544–550. 10.1016/0006-291X(73)91177-7CrossRef
14.
go back to reference Liewendahl K, Majuri H, Helenius T: Thyroid function tests in patients on long-term treatment with various anticonvulsivant drugs. Clin Endocrinol 1978, 8: 185–191. 10.1111/j.1365-2265.1978.tb01493.xCrossRef Liewendahl K, Majuri H, Helenius T: Thyroid function tests in patients on long-term treatment with various anticonvulsivant drugs. Clin Endocrinol 1978, 8: 185–191. 10.1111/j.1365-2265.1978.tb01493.xCrossRef
15.
go back to reference Smith PJ, Surks MI: Multiple effects of 5,5’-diphenylhydantoin on the thyroid hormone system. Endocr Rev 1984, 5: 514–524. 10.1210/edrv-5-4-514PubMedCrossRef Smith PJ, Surks MI: Multiple effects of 5,5’-diphenylhydantoin on the thyroid hormone system. Endocr Rev 1984, 5: 514–524. 10.1210/edrv-5-4-514PubMedCrossRef
16.
go back to reference Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S, Nicoloff J: Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987, 33: 1391–1396.PubMed Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S, Nicoloff J: Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987, 33: 1391–1396.PubMed
17.
go back to reference Larkin JG, Macphee GJA, Beastall GH, Brodie MJ: Thyroid hormone concentrations in epileptic patients. Eur J Clin Pharmacol 1989, 36: 213–216. 10.1007/BF00558149PubMedCrossRef Larkin JG, Macphee GJA, Beastall GH, Brodie MJ: Thyroid hormone concentrations in epileptic patients. Eur J Clin Pharmacol 1989, 36: 213–216. 10.1007/BF00558149PubMedCrossRef
18.
go back to reference Davies PH, Franklyn JA: The effects of drugs on tests of thyroid function. Eur J Clin Pharmacol 1991, 40: 439–451. 10.1007/BF00315221PubMedCrossRef Davies PH, Franklyn JA: The effects of drugs on tests of thyroid function. Eur J Clin Pharmacol 1991, 40: 439–451. 10.1007/BF00315221PubMedCrossRef
19.
go back to reference Stockigt JR: ree thyroid hormone measurement. A Crit appraisal 2001 Endocrinol Metab Clin North Am 2001, 30: 265–289. Stockigt JR: ree thyroid hormone measurement. A Crit appraisal 2001 Endocrinol Metab Clin North Am 2001, 30: 265–289.
20.
go back to reference Steele BW, Wang E, Klee GG, Thienpont LM, Soldin SJ, Sokoll LJ, Winter WE, Fuhrman SA, Elin RJ: Analytic bias of thyroid function tests: analysis of a college of American Pathologists fresh frozen serum pool by 3900 clinical laboratories. Arch Pathol Lab Med 2005, 129: 310–317.PubMed Steele BW, Wang E, Klee GG, Thienpont LM, Soldin SJ, Sokoll LJ, Winter WE, Fuhrman SA, Elin RJ: Analytic bias of thyroid function tests: analysis of a college of American Pathologists fresh frozen serum pool by 3900 clinical laboratories. Arch Pathol Lab Med 2005, 129: 310–317.PubMed
21.
go back to reference Crofton KM: Thyroid disrupting chemicals: mechanisms and mixtures. Int J Androl 2008, 31: 209–223. 10.1111/j.1365-2605.2007.00857.xPubMedCrossRef Crofton KM: Thyroid disrupting chemicals: mechanisms and mixtures. Int J Androl 2008, 31: 209–223. 10.1111/j.1365-2605.2007.00857.xPubMedCrossRef
22.
go back to reference Stockigt JR, Lim CF: Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Clin Endocrinol Metab 2009, 23: 753–767. 10.1016/j.beem.2009.06.004CrossRef Stockigt JR, Lim CF: Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Clin Endocrinol Metab 2009, 23: 753–767. 10.1016/j.beem.2009.06.004CrossRef
23.
go back to reference Beckett GJ: Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010, 205: 1–13. 10.1677/JOE-09-0412PubMedCrossRef Beckett GJ: Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010, 205: 1–13. 10.1677/JOE-09-0412PubMedCrossRef
24.
go back to reference Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA: Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012, 22: 1200–1235. 10.1089/thy.2012.0205PubMedCrossRef Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA: Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 2012, 22: 1200–1235. 10.1089/thy.2012.0205PubMedCrossRef
25.
go back to reference Dixon WJ: Processing data for outliers. Biometrics 1953, 9: 74–89. 10.2307/3001634CrossRef Dixon WJ: Processing data for outliers. Biometrics 1953, 9: 74–89. 10.2307/3001634CrossRef
26.
go back to reference Harris EK, Boyd JC: On dividing reference data into subgroups to produce reference ranges. Clin Chem 1990, 36: 265–270.PubMed Harris EK, Boyd JC: On dividing reference data into subgroups to produce reference ranges. Clin Chem 1990, 36: 265–270.PubMed
27.
go back to reference Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13: 3–126.PubMedCrossRef Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13: 3–126.PubMedCrossRef
28.
go back to reference Benhaldi N, Fliers E, Visser TJ, Reitsma JB, Wiersinga WM: Pilot study on the assessment of the setpoint on the hypothalamus-pituitary-tryroid axis in healthy volunteers. Eur J Endocrinol 2010, 162: 323–329. 10.1530/EJE-09-0655CrossRef Benhaldi N, Fliers E, Visser TJ, Reitsma JB, Wiersinga WM: Pilot study on the assessment of the setpoint on the hypothalamus-pituitary-tryroid axis in healthy volunteers. Eur J Endocrinol 2010, 162: 323–329. 10.1530/EJE-09-0655CrossRef
29.
go back to reference Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J: New reference intervals for thyrotropin and thyroid hormones based on national academy of clinical biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005, 51: 1480–1486. 10.1373/clinchem.2004.047399PubMedCrossRef Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J: New reference intervals for thyrotropin and thyroid hormones based on national academy of clinical biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005, 51: 1480–1486. 10.1373/clinchem.2004.047399PubMedCrossRef
30.
go back to reference D’Herbomez M, Jarrige V, Darte C: Reference intervals for serum thyrotropin (TSH) and free thyroxine (FT4) in adults using the Access Immunoassay System. Clin Chem Lab Med 2005, 43: 102–105.PubMed D’Herbomez M, Jarrige V, Darte C: Reference intervals for serum thyrotropin (TSH) and free thyroxine (FT4) in adults using the Access Immunoassay System. Clin Chem Lab Med 2005, 43: 102–105.PubMed
31.
go back to reference Brochmann H, Bjøro T, Gaarder PI, Hanson F, Frey HM: Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (Naerøy). Acta Endocrinol (Copenh) 1988, 117: 7–12. Brochmann H, Bjøro T, Gaarder PI, Hanson F, Frey HM: Prevalence of thyroid dysfunction in elderly subjects. A randomized study in a Norwegian rural community (Naerøy). Acta Endocrinol (Copenh) 1988, 117: 7–12.
32.
go back to reference Boucai L, Hollowell JG, Surks MI: An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011, 21: 5–11. 10.1089/thy.2010.0092PubMedCentralPubMedCrossRef Boucai L, Hollowell JG, Surks MI: An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011, 21: 5–11. 10.1089/thy.2010.0092PubMedCentralPubMedCrossRef
33.
go back to reference Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I: Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009, 94: 1251–1254. 10.1210/jc.2008-2325PubMedCentralPubMedCrossRef Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I: Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009, 94: 1251–1254. 10.1210/jc.2008-2325PubMedCentralPubMedCrossRef
34.
go back to reference Surks MI, Boucai L: Age- and race- based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010, 95: 496–502. 10.1210/jc.2009-1845PubMedCrossRef Surks MI, Boucai L: Age- and race- based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010, 95: 496–502. 10.1210/jc.2009-1845PubMedCrossRef
35.
go back to reference Estrada JM, Soldin D, Buckey TM, Burman KD, Soldin OP: Thyrotropin isoforms – implications for TSH analysis and clinical practice. Thyroid 2013. in press Estrada JM, Soldin D, Buckey TM, Burman KD, Soldin OP: Thyrotropin isoforms – implications for TSH analysis and clinical practice. Thyroid 2013. in press
36.
go back to reference Mariotti S, Franceschi C, Cossarizza A, Pinchera A: The aging thyroid. Endocr Rev 1995, 16: 686–715.PubMedCrossRef Mariotti S, Franceschi C, Cossarizza A, Pinchera A: The aging thyroid. Endocr Rev 1995, 16: 686–715.PubMedCrossRef
37.
go back to reference Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG: Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004, 292: 2591–2599. 10.1001/jama.292.21.2591PubMedCrossRef Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG: Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004, 292: 2591–2599. 10.1001/jama.292.21.2591PubMedCrossRef
38.
go back to reference Van Den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SWJ: Thyroid hormone concentrations, disease, physical function, and mortality in elderly Men. J Clin Endocrinol Metab 2005, 90: 6403–6409. 10.1210/jc.2005-0872PubMedCrossRef Van Den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SWJ: Thyroid hormone concentrations, disease, physical function, and mortality in elderly Men. J Clin Endocrinol Metab 2005, 90: 6403–6409. 10.1210/jc.2005-0872PubMedCrossRef
39.
go back to reference Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, Sheppard MC, Franklyn JA: Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007, 167: 928–934. 10.1001/archinte.167.9.928PubMedCrossRef Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, Sheppard MC, Franklyn JA: Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007, 167: 928–934. 10.1001/archinte.167.9.928PubMedCrossRef
40.
go back to reference Heeringa J, Hoogendoorn EH, von der Deure WM, Hofman A, Peeters RP, Hop WCJ, den Heijer M, Visser TJ, Witterman JCM: High-normal thyroid function and risk of atrial fibrillation. The rotterdam study. Arch intern Med 2008, 168: 2219–2224. 10.1001/archinte.168.20.2219PubMedCrossRef Heeringa J, Hoogendoorn EH, von der Deure WM, Hofman A, Peeters RP, Hop WCJ, den Heijer M, Visser TJ, Witterman JCM: High-normal thyroid function and risk of atrial fibrillation. The rotterdam study. Arch intern Med 2008, 168: 2219–2224. 10.1001/archinte.168.20.2219PubMedCrossRef
41.
go back to reference Peeters RP: Thyroid function and longevity: New insights into an Old dilemma. J Clin Endocrinol Metab 2009, 94: 4658–4660. 10.1210/jc.2009-2198PubMedCrossRef Peeters RP: Thyroid function and longevity: New insights into an Old dilemma. J Clin Endocrinol Metab 2009, 94: 4658–4660. 10.1210/jc.2009-2198PubMedCrossRef
42.
go back to reference Biondi B, Cooper DS: The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29: 76–131.PubMedCrossRef Biondi B, Cooper DS: The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29: 76–131.PubMedCrossRef
43.
go back to reference Laurberg P, Andersen S, Carle A, Karmisholt J, Knudsen N, Pedersen IB: The TSH upper reference limit: where are we at? Nat Rev Endocrinol 2011, 7: 232–239. 10.1038/nrendo.2011.13PubMedCrossRef Laurberg P, Andersen S, Carle A, Karmisholt J, Knudsen N, Pedersen IB: The TSH upper reference limit: where are we at? Nat Rev Endocrinol 2011, 7: 232–239. 10.1038/nrendo.2011.13PubMedCrossRef
44.
go back to reference Tseng F-Y, Lin W-Y, Lin C-C, Lee L-T, Li T-C, Sung P-K, Huang K-C: Subclinical hypothyroidism is associated with increased risk for All-cause and cardiovascular mortality in adults. J Am col Cardiol 2012, 60: 730–737. 10.1016/j.jacc.2012.03.047CrossRef Tseng F-Y, Lin W-Y, Lin C-C, Lee L-T, Li T-C, Sung P-K, Huang K-C: Subclinical hypothyroidism is associated with increased risk for All-cause and cardiovascular mortality in adults. J Am col Cardiol 2012, 60: 730–737. 10.1016/j.jacc.2012.03.047CrossRef
45.
go back to reference Wartofsky L, Dickey RA: The evidence for a narrower thyrotropin reference range is compelling 2005. J Clin Endocrinol Metab 2005, 90: 5483–5488. 10.1210/jc.2005-0455PubMedCrossRef Wartofsky L, Dickey RA: The evidence for a narrower thyrotropin reference range is compelling 2005. J Clin Endocrinol Metab 2005, 90: 5483–5488. 10.1210/jc.2005-0455PubMedCrossRef
Metadata
Title
Reference interval of thyroid stimulating hormone and free thyroxine in a reference population over 60 years old and in very old subjects (over 80 years): comparison to young subjects
Authors
Rosita Fontes
Claudia Regina Coeli
Fernanda Aguiar
Mario Vaisman
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Thyroid Research / Issue 1/2013
Electronic ISSN: 1756-6614
DOI
https://doi.org/10.1186/1756-6614-6-13

Other articles of this Issue 1/2013

Thyroid Research 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine